長讀測序市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按組件、技術、工作流程、應用、終端用戶、公司和地區分類
市場調查報告書
商品編碼
1289651

長讀測序市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按組件、技術、工作流程、應用、終端用戶、公司和地區分類

Long Read Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Technology, By Workflow, By Application, By End User, By Region, By company and By Region

出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球長讀測序市場預計將在2023-2027年預測期內出現令人印象深刻的成長。主要因素包括遺傳性疾病的發生率越來越高,政府對研發活動的支持越來越多,以及技術的廣泛發展正在推動市場的成長。長讀測序,也被稱為第三代測序,是一種正在研究的DNA測序技術。它可以一次確定10,000到100,000個鹼基對之間的長序列DNA的核苷酸序列。這項技術消除了其他DNA測序方法中通常需要的切割和然後擴增DNA的需要。支持市場成長的其他因素有:研發活動的增加,包括癌症在內的遺傳病患者數量的增加,臨床試驗數量的增加,個性化醫療的普及,現代醫療診斷方法的接受度的增加,醫療機構出於學術目的對序列分析方法的使用增加,世界人口的增加,無機成長戰略的採用增加,以及新興子市場的巨大潛力。

遺傳性疾病發病率的上升

遺傳性疾病,如色盲、唐氏綜合症、囊性纖維化等,在全球範圍內的發病率越來越高,這促進了市場的成長。根據世界衛生組織(WHO)的數據,超過10,000種疾病是已知的單基因疾病,由人類DNA中的一個單一基因錯誤引發的。在長線測序方法的幫助下,病人的整個基因組學可以得到檢查。因此,在治療遺傳病方面,長讀測序的採用率上升了。患有遺傳病的病人越來越多,也是促進市場成長的一個因素。根據世界衛生組織(WHO)的數據,鐮刀型細胞貧血症是一種嚴重的遺傳病,影響到大約72000名新生兒。

政府對研發活動的支持不斷增加

使用長讀測序方法的研究越來越多,受到政府當局的大力資助,這是市場成長的一個關鍵原因。此外,研究活動數量的增加也促進了市場的成長。例如,在美國,基因組學研究和開發項目是通過美國國家衛生研究院(NIH)以及全球眾多其他團體資助的。目前,大量的研究活動正在進行,預計這將使製造商在開發新的和先進的長讀測序時具有優勢,並為長讀測序市場帶來許多機會。例如,在美國,基因組學研究和開發項目是通過美國國家衛生研究院(NIH)以及全球各地的許多其他團體資助的。

技術進步

測序儀技術進步的興起正在推動市場的成長。這些進步使測序更加高效、準確和攜帶。例如,SMRT測序儀產生的長讀數跨越了可能的重複區域,並提供了整個基因組的全面視圖。同樣,在2018年,加州太平洋生物科學公司(PacBio)宣布加強他們的Sequel系統,其中包括新版本的軟體,新的消耗品,包括試劑和新的SMRT細胞(1M v3)。

可用的定製產品

利用給定的市場數據,TechSci Research根據公司的具體需要提供定製服務。該報告有以下定製選項:

公司資訊

  • 其他市場參與者(最多5家)的詳細分析和概況。

目錄

第一章:產品概述

第二章:研究方法

第三章:COVID-19對全球長讀測序市場的影響

第四章:客戶的聲音

第五章:執行摘要

第六章:全球長讀測序市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按組件(儀器、消耗品、服務)分類
    • 按技術分類(單分子即時測序(SMRT),奈米孔測序,其他)
    • 按工作流程(預測序、測序、數據分析)分類
    • 按應用(腫瘤、傳染病、罕見病、遺傳性疾病、代謝性疾病、其他)分類
    • 按終端用戶(醫院和診所、生物技術和製藥公司、學術和研究機構、其他)分類
    • 按地區分類
    • 按公司分類(2021年)
  • 市場地圖

第七章:北美長讀測序市場前景

  • 市場規模和預測
    • 按價值分類
  • 市場佔有率與預測
    • 按組件分類
    • 按技術分類
    • 按工作流程分類
    • 按應用
    • 按終端用戶
    • 按國家分類
  • 北美洲:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章:歐洲長讀測序市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件分類
    • 按技術分類
    • 按工作流程分類
    • 按應用
    • 按終端用戶
    • 按國家分類
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章:亞太地區長讀測序市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件分類
    • 按技術分類
    • 按工作流程分類
    • 按應用
    • 按終端用戶
    • 按國家分類
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第十章:南美長讀測序市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件分類
    • 按技術分類
    • 按工作流程分類
    • 按應用
    • 按終端用戶
    • 按國家分類
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章:中東和非洲長讀測序市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按組件分類
    • 按技術分類
    • 按工作流程分類
    • 按應用
    • 按終端用戶
    • 按國家分類
  • MEA: 國家分析
    • 南非長讀測序
    • 沙烏地長讀測序
    • 阿拉伯聯合大公國長讀測序

第12章:市場動態

  • 驅動力
  • 挑戰

第十三章:市場趨勢與發展

第十四章:競爭格局

  • Agilent Technologies, Inc.BGI Group Bionano Genomics, Inc.Circulomics Inc Oxford Nanopore Technologies plc Longas Technologies Pty Ltd Novogene Co.Illumina, Inc.F. Hoffmann-La Roche AG Pacific Biosciences of California, Inc.Quantapore, Inc.QIAGEN NV PerkinElmer, Inc Thermo Fischer Scientific, Inc.Takara Bio, Inc.

第十五章:戰略建議

簡介目錄
Product Code: 13056

The global long-read sequencing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing occurrences of genetic disorders, growing government support for R&D activities, and extensive development in technology are fueling the growth of the market. Long-read sequencing, also known as third-generation sequencing, is a DNA sequencing technique that is being researched. It can determine the nucleotide sequence of long sequences of DNA ranging between 10,000 and 100,000 base pairs at a time. This technology eliminates the need to cut up and then amplify DNA which is usually needed in other DNA sequencing methods. The other factors supporting the market's growth are, a rise in R&D activities, a growing number of patients with genetic diseases, including cancer, an increasing number of clinical trials, the rising popularity of personalized medicine, increasing acceptance of modern approaches for medical diagnostics, rising utilization of sequence analysis methodologies in medical institutes for academic purposes, rise in world population, growing adoption of inorganic growth strategies, and immense potential for emerging submarkets.

The surge in Incidences of Genetic Disorders

The increasing prevalence of genetic diseases, such as color blindness, Down's syndrome, cystic fibrosis, and others, across the globe is bolstering the growth of the market. According to the World Health Organization (WHO), more than 10,000 of the diseases are known to be monogenic, triggered by a single error in a single gene in the human DNA. With the help of long-read sequencing methods, the whole genomics of the patient can be examined. Thus, rising the adoption of long-read sequencing in the treatment of genetic conditions. The growing number of patients suffering from genetic diseases is also a contributing factor to the growth of the market. According to the World Health Organization (WHO), sickle cell anemia, a severe genetic condition, affects about 72,000 newborn babies.

Increasing Government Support for R&D Activities

The increasing research which uses long-read sequencing methods is being heavily funded by government authorities, which is a key reason for the growth of the market. Moreover, the rising number of research activities is augmenting the growth of the market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe. Presently, numerous amounts of research activities are being performed, which is projected to give manufacturers an advantage as they develop new and advanced long-read sequencing, as well as to open many opportunities in the long-read sequencing market. For instance, in the U.S., genomics research and development projects are funded through the National Institutes of Health (NIH) as well as numerous other groups from around the globe.

Technological advancements

The rise in technological advancements in sequencers is propelling the growth of the market. These advancements have made sequencing more efficient, accurate, and portable. For instance, long reads generated by SMRT sequencers span around possible repetitive regions and give a comprehensive view of the whole genome. Similarly, in 2018, Pacific Biosciences of California (PacBio) announced the enhancements to their Sequel System, which comprises a new version of its software, new consumables including reagents, and a new SMRT Cell (1M v3).

Market Segmentation

The global long-read sequencing market is segmented into components, technology, workflow, application, end user, and company. Based on components, the market is divided into instruments, consumables, and services. Based on technology, the market is divided into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. Based on application, the market is divided into oncology, infectious diseases, rare diseases, genetic disorders, metabolic disorders, and others. Based on end-user, the market is divided into hospitals & clinics, biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising incidences of hematologic malignancies in the country.

Market Players

Agilent Technologies, Inc., BGI Group, Bionano Genomics, Inc., Circulomics Inc, Oxford Nanopore Technologies plc, Longas Technologies Pty Ltd, Novogene Co., Ltd., Illumina, Inc., F. Hoffmann-La Roche AG, Pacific Biosciences of California, Inc., Quantapore, Inc., QIAGEN NV, PerkinElmer, Inc, Thermo Fischer Scientific, Inc., and Takara Bio, Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global long-read sequencing market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Long Read Sequencing Market, By Component:

  • Instruments
  • Consumables
  • Services

Long Read Sequencing Market, By Technology:

  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing
  • Others

Long Read Sequencing Market, By Workflow:

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Long Read Sequencing Market, By Application:

  • Oncology
  • Infectious Diseases
  • Rare Diseases
  • Genetic Disorders,
  • Metabolic Disorders
  • Others

Long Read Sequencing Market, By End User:

  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Companies,
  • Academic & Research Institutions
  • Others

Long Read Sequencing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Long Read Sequencing Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Long Read Sequencing Market

4. Voice of Customer

5. Executive Summary

6. Global Long Read Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Instruments, Consumables, Services)
    • 6.2.2. By Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing, Others)
    • 6.2.3. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
    • 6.2.4. By Application (Oncology, Infectious Diseases, Rare Diseases, Genetic Disorders, Metabolic Disorders, Others)
    • 6.2.5. By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Long Read Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technology
    • 7.2.3. By Workflow
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Long Read Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Workflow
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Mexico Long Read Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Workflow
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Canada Long Read Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Workflow
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Long Read Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technology
    • 8.2.3. By Workflow
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Long Read Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Workflow
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Long Read Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Workflow
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Long Read Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Workflow
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Long Read Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Workflow
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Long Read Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Workflow
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Long Read Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technology
    • 9.2.3. By Workflow
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Long Read Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Workflow
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Long Read Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Workflow
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Long Read Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Workflow
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Long Read Sequencing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Workflow
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Long Read Sequencing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Workflow
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Long Read Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technology
    • 10.2.3. By Workflow
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Long Read Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Workflow
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Long Read Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Workflow
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Long Read Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Workflow
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Long Read Sequencing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component
    • 11.2.2. By Technology
    • 11.2.3. By Workflow
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Long Read Sequencing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Workflow
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Long Read Sequencing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Workflow
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Long Read Sequencing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Workflow
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Agilent Technologies, Inc.
  • 14.2. BGI Group
  • 14.3. Bionano Genomics, Inc.
  • 14.4. Circulomics Inc
  • 14.5. Oxford Nanopore Technologies plc
  • 14.6. Longas Technologies Pty Ltd
  • 14.7. Novogene Co., Ltd.
  • 14.8. Illumina, Inc.
  • 14.9. F. Hoffmann-La Roche AG
  • 14.10. Pacific Biosciences of California, Inc.
  • 14.11. Quantapore, Inc.
  • 14.12. QIAGEN NV
  • 14.13. PerkinElmer, Inc
  • 14.14. Thermo Fischer Scientific, Inc.
  • 14.15. Takara Bio, Inc.

15. Strategic Recommendations